This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Table of Contents Why Keyword Research for PPC Matters in Pharma Marketing Understanding Pharma-Specific PPC Challenges Best Practices for Pharma Keyword Research Optimizing PPC Campaigns for Compliance and ROI Why Keyword Research for PPC Matters in Pharma Marketing Keyword research for PPC is the foundation of any successful pharma marketing strategy.
Health care practitioners (HCPs), and patients too, are sounding the alarm on unnecessary barriers in the system that can negatively impact patients’ access to quality care according to a new survey of HCPs and patients. Specifically, HCPs raised concerns over how pharmacy benefit managers (PBMs) and insurers inappropriately use utilization management tools, like prior authorization, to deny or delay care, ultimately harming the patient and impacting patient access to care.
SM is a 48-year-old female who has new-onset symptoms of restlessness, irritability, insomnia, and vivid nightmares. Over the past 3 months, she has also experienced increasing anxiety and mood swings. She reports a feeling of impending doom and difficulty concentrating, which has begun to affect her daily life and work performance. She has a past […] The post Montelukast Causes The Prescribing Cascade – Case Study appeared first on Med Ed 101.
The evolution of PQAs continued involvement in medication therapy management (MTM) spans over a decade. Milestones include endorsement of the Completion Rate for Comprehensive Medication Review performance measure in 2011 and development of the foundational Medication Therapy Problem Categories Framework in 2017. In 2023, PQA launched a multiphase national MTM initiative to address stakeholder needs and advance MTM quality measurement.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
From 25 th February until Rare Disease Day (28 th February), NF2 BioSolutions UK & Europe held an exhibition at the Nottingham Central Library to raise awareness of NF2 and to shine a light on those with NF2 who have bravely shared their stories with us for our popular social media campaign. [IMAGE DESCRIPTION] The NF2 BioSolutions Exhibition stall at Nottingham Central Library, with a standing banner describing the origin and effects of NF2-SWN, and a table full of posters telling the indiv
The American Conference Institutes 21st Annual Paragraph IV Disputes is scheduled to take place from April 29-30, 2025 at The Altman Building in New York, NY. Widely recognized as the industry gold standard, the conference unites leaders from brand-name and generic drug companies, alongside federal judges, the U.S. PTOs PTAB, the FTC, and the FDA, to tackle the critical legal, regulatory, and business issues shaping pharmaceutical patent litigation.
MSD has announced it has opened a new $1 billion vaccine manufacturing facility at its site in Durham, North Carolina, US. “Expanding our state-of-the-art manufacturing facility in Durham marks a significant milestone in our efforts to strengthen our production and manufacturing capabilities in the US,” commented Sanat Chattopadhyay, Executive Vice President and President, Merck Manufacturing Division.
MSD has announced it has opened a new $1 billion vaccine manufacturing facility at its site in Durham, North Carolina, US. “Expanding our state-of-the-art manufacturing facility in Durham marks a significant milestone in our efforts to strengthen our production and manufacturing capabilities in the US,” commented Sanat Chattopadhyay, Executive Vice President and President, Merck Manufacturing Division.
For the Rev. Beth Stotts, death is a natural part of her ministry. A major aspect of her job is guiding her congregants through their most vulnerable moments from birth throughout life. The struggles she has seen in her community led her to seek more training to help people face death, and in 2022 she added another credential to her spiritual one: end-of-life doula.
The ultimate guide to 2025 healthcare and life sciences conferences Stay ahead of the latest developments and networking opportunities in the health and life sciences sector with Fulds 2025 Health & Life Sciences Conference Directory. This comprehensive resource provides a detailed calendar of key healthcare conferences happening across the US and Europe in 2025, all in a single, easy-to-access document.
Y ou’re reading the web edition of STAT’s AI Prognosis newsletter, our subscriber-exclusive guide to artificial intelligence in health care and medicine. Sign up to get it delivered in your inbox every Wednesday. Patients prefer messages that are written by AI, but they like them less when they’re told the message was AI-drafted, says a new study that came out yesterday in JAMA Network Open.
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Good morning, everyone, and welcome to the middle of the week. Congratulations on making it this far, and remember there are only a few more days until the weekend arrives. So keep plugging away. After all, what are the alternatives? While you ponder the possibilities, we invite you to join us for a delightful cup of stimulation. Our choice today is, once again, maple cinnamon French toast.
Tuesday marked the fifth anniversary of the World Health Organization declaring Covid-19 a global pandemic. For science writer Carl Zimmer, a columnist for the New York Times, covering Covid meant “watching [scientists] figuring out this disease in real time.” Notably, “there were a lot of mysteries about it. I was really struck as, as others were, by how strange it was that, that the just a fundamental question of how Covid spread was so unclear and was leading to so much a
Representatives from Cencoras Good Neighbor Pharmacy Network discussed legislation created to improve declining pharmacy rates and who is accountable for addressing pharmacy deserts.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
After a year of controversy and complaints, U.S. Sen. Elizabeth Warren (D-Mass.) is asking a federal watchdog to investigate GSK for replacing a popular asthma inhaler with a so-called authorized generic at a much higher price in order to avoid paying Medicaid rebates. In a letter sent Tuesday to the Office of Inspector General at the U.S. Department of Health and Human Services, Warren accused the company of “outrageous profiteering” because the maneuver cost Medicaid nearly $1 bi
LONDON — Looking to expand its obesity offerings, Roche on Wednesday said it had partnered with Zealand Pharma to license an experimental weight loss drug for $1.65 billion in upfront cash. The Swiss pharma giant and the Danish biotech will now work together to develop Zealand’s drug candidate petrelintide, aiming to test it on its own and in combination with Roche’s experimental CT-388.
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Reports of a new federal plan to study whether there’s a link between vaccines and autism could serve as an early test of the commitments Sen. Bill Cassidy (R-La.) said he received from Robert F. Kennedy Jr. in exchange for his support for RFK Jr.’s confirmation as Health and Human Services secretary. On Friday, multiple news outlets reported that the Centers for Disease Control and Prevention was planning the study.
A long-term project from contractors to modernize a provider enrollment system for Medicare is the latest casualty of DOGE and will now be completed in-house, the agency recently announced. Whether that decision is a good or bad one is up for debate.
Notify.gov, a mass texting service created to better communicate renewal deadlines and eligibility for benefit programs like Medicaid, will not be operational.
Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds. Sign up here. Hello all, this is Allison DeAngelis, filling in for your Morning Rounds maven Theresa Gaffney.
A recent analysis, which looked at ophthalmology practice acquisitions between 2014 and 2021, outlines movement among the clinical workforce and changes in its characteristics that stem from private equity's increasing role in care.
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Good morning, hope everyone is enjoying the warmer weather and longer days. Let’s get into the news today.
Some health tech companies help providers communicate more proactively with patients about what they might owe and what repayment options are available to them.
We organize all of the trending information in your field so you don't have to. Join 5,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content